BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr | ₹689 Cr |
What is the latest Revenue of BLISS GVS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹770 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹577 Cr |
| Mar2021 | ₹689 Cr |
How is Revenue of BLISS GVS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹770 Cr | 2.48 | |
| Mar2024 | ₹752 Cr | 0.55 | |
| Mar2023 | ₹747 Cr | 29.50 | |
| Mar2022 | ₹577 Cr | -16.26 | |
| Mar2021 | ₹689 Cr | - | |
Compare Revenue of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,554.7 Cr | -14.1% | -8.3% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,536.0 Cr | 0.1% | 4.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,753.0 Cr | -0.6% | -1.3% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,650.0 Cr | 0.5% | -0.6% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,143.0 Cr | -0.6% | -0.5% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,244.0 Cr | -0.2% | 3.6% | -0.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -14.1% |
-8.3% |
-3.2% |
| SENSEX | -0.5% |
1.1% |
3.8% |
You may also like the below Video Courses